Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's related topics section gained entries for Melanoma and MedlinePlus Genetics, expanding access to disease context and genetics resources.
    Difference
    0.2%
    Check dated 2026-07-18T20:38:51.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Removed Melanoma, the related topics heading, and MedlinePlus Genetics from the page's related topics area, reducing cross-links to these topics.
    Difference
    0.2%
    Check dated 2026-07-11T17:02:52.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows a newer revision version (v3.6.3) replacing the previous v3.6.2, reflecting a maintenance/update of the page template. This update does not modify any study content or trial details.
    Difference
    0.1%
    Check dated 2026-07-04T13:36:11.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a new revision of the page content.
    Difference
    0.1%
    Check dated 2026-06-27T07:50:04.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now includes Melanoma as a topic and a related topics section featuring MedlinePlus Genetics, expanding cross-linking to melanoma and genetics resources.
    Difference
    0.2%
    Check dated 2026-06-20T08:50:48.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page now indicates recruitment has ended ('No longer looking for participants') and adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), while some headings (Intervention / Treatment) are removed or renamed, indicating a reorganization of the study details.
    Difference
    0.6%
    Check dated 2026-06-13T05:20:15.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.